PDO-Based Drug Screening in Advanced Pancreatic Cancer.
0/5 보강
APA
Liang C, Shan D, Wei Z (2025). PDO-Based Drug Screening in Advanced Pancreatic Cancer.. Gastroenterology, 168(3), 627-628. https://doi.org/10.1053/j.gastro.2024.10.045
MLA
Liang C, et al.. "PDO-Based Drug Screening in Advanced Pancreatic Cancer.." Gastroenterology, vol. 168, no. 3, 2025, pp. 627-628.
PMID
39571820 ↗
같은 제1저자의 인용 많은 논문 (5)
- Defining the role of natural killer cells in acute myeloid leukemia through the lens of single-cell omics.
- Bronchial Arterial Chemoembolization Combined with Tislelizumab for Non-Small Cell Lung Cancer: An Exploratory, Prospective, Single-Arm, Phase II Trial.
- Gilteritinib maintenance after allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia with FLT3-internal tandem duplication mutation.
- Efficacy and safety of immunotherapy-based neoadjuvant regimens in locally advanced gastric cancer: a meta-analysis based on high-quality clinical trials.
- The prognostic impact of body mass index on patients with gastric adenocarcinoma and mucinous adenocarcinoma: a retrospective cohort study.